Wound closure tech developer Clozex Medical raised approximately $3.8 million in a new round of equity financing, according to a recently posted SEC filing.
Funds in the round came from 39 unnamed sources, with the first sale dated on October 16, according to the filing.
Wellesley, Mass.-based Clovex is developing wound closure products intended to address limitations of traditional suture and stapling techniques. It’s flagship technology is Clozex Closures, which are intended for multiple uses, including plastic surgery, orthopedics, dermatology, cardiothoracic surgery, emergency medicine and urgent care, according to the company’s website.
The company is looking to raise an additional approximate $490,000 in the round, which would bring the total raised up to approximately $4.3 million, according to the SEC filing.
Clozex has not yet officially stated how it plans to spend funds raised in the round.